Le Lézard
Classified in: Health, Science and technology
Subjects: AWD, TDS

Dr. Ge Li Awarded "CEO of the Year" at CPhI Worldwide 2019

SHANGHAI, Nov. 10, 2019 /PRNewswire/ -- WuXi AppTec, a leading global provider of R&D and manufacturing services enabling companies in the pharmaceutical, biotechnology and medical device industries, announced today that its Chairman and CEO Dr. Ge Li was awarded "CEO of the Year" at the CPhI Worldwide 2019, a top pharmaceutical event uniting over 45,000 professionals worldwide.

The 2019 CPhI Pharma Awards recognize the innovation and dedication of companies and individuals who are driving the pharmaceutical industry forward. Its Judging Panel is comprised of independent, senior industry experts from around the world, each chosen for their knowledge, objectivity and credibility.

Dr. Ge Li was chosen for his significant contribution to the global biopharma R&D industry. "Under his leadership, WuXi AppTec has become a highly respected contributor to global healthcare innovation. The company is enabling more than 3,700 customers and partners in more than 30 countries by offering open-access capabilities and services, accelerating the discovery and development of new medicines for patients around the world."

"I'm honored by this award and its recognition of WuXi's global platform," said Dr. Ge Li, Chairman and CEO of WuXi AppTec. "It's been our great privilege to serve our innovative partners around the world and help bring some of the most needed medicines closer to patients."

About WuXi AppTec

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve the productivity of advancing healthcare products through cost-effective and efficient solutions. With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,700 collaborators from over 30 countries to improve the health of those in need ? and to realize our vision that "every drug can be made and every disease can be treated." Please visit: http://www.wuxiapptec.com


These press releases may also interest you

at 10:05
Supercomputing 2019 (booth #1889) -- Liqid, provider of the world's most comprehensive composable infrastructure platform, announced today the company's composable infrastructure software can disaggregate traditional, off-the-shelf converged servers...

at 10:05
Terramera®, the cleantech leader focused on fusing science, nature and artificial intelligence to create revolutionary technologies that transform how we grow food and solve global challenges through tech and farming, today announced that four...

at 10:05
ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world's most advanced next generation pertussis vaccine, today announced expansion of its executive team. Following closely after full enrollment of its Phase 2b...

at 10:05
Shield Compliance (https://www.shieldbanking.com/) has signed new agreements to provide its compliance management platform to financial institutions serving legal cannabis markets in Colorado, Illinois, Massachusetts, Michigan, Ohio, and Washington....

at 10:05
Red Hat, Inc., the world's leading provider of open source solutions, today announced the release of Red Hat CodeReady Workspaces 2, a cloud-native development workflow for developers. The new release of CodeReady Workspaces enables developers to...

at 10:05
Supercomputing 2019 (booth #1889) -- Liqid, provider of the world's most comprehensive composable infrastructure platform, today announced its collaboration with Western Digital (booth #1275) to demonstrate NVMe over Fabrics (NVMe-oFtm), leveraging...

News published on 10 november 2019 at 19:00 and distributed by: